Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma

por Khorasanchi, Adam, Wu, Richard, Kendra, Kari, Verschraegen, Claire
Publicado 2022

Refractory dermatitis contributed by pityriasis versicolor: a case report

por Li, Mingjia, Spaccarelli, Natalie, Kendra, Kari, Wu, Richard C., Verschraegen, Claire
Publicado 2021

BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma

por Wolfe, Adam R., Chablani, Priyanka, Siedow, Michael R., Miller, Eric D., Walston, Steve, Kendra, Kari L., Wuthrick, Evan, Williams, Terence M.
Publicado 2021

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

por Monk, Paul, Lam, Elaine, Mortazavi, Amir, Kendra, Kari, Lesinski, Gregory B., Mace, Thomas A., Geyer, Susan, Carson, William E., Tahiri, Sanaa, Bhinder, Arvinder, Clinton, Steven K., Olencki, Thomas
Publicado 2014

Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells

por Yang, Jennifer, Bill, Matthew A., Young, Gregory S., La Perle, Krista, Landesman, Yosef, Shacham, Sharon, Kauffman, Michael, Senapedis, William, Kashyap, Trinayan, Saint-Martin, Jean-Richard, Kendra, Kari, Lesinski, Gregory B.
Publicado 2014

A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma

por Hasanov, Merve, Rioth, Matthew J., Kendra, Kari, Hernandez-Aya, Leonel, Joseph, Richard W., Williamson, Stephen, Chandra, Sunandana, Shirai, Keisuke, Turner, Christopher D., Lewis, Karl, Crowley, Elizabeth, Moscow, Jeffrey, Carter, Brett, Patel, Sapna
Publicado 2020

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

por Li, Mingjia, Spakowicz, Daniel, Burkart, Jarred, Patel, Sandip, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Carbone, David P., Verschraegen, Claire F., Presley, Carolyn J., Otterson, Gregory A., Kendra, Kari, Owen, Dwight H.
Publicado 2019

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

por Suarez-Kelly, Lorena P., Levine, Kala M., Olencki, Thomas E., del Campo, Sara E. Martin, Streacker, Elizabeth A., Brooks, Taylor R., Karpa, Volodymyr I., Markowitz, Joseph, Bingman, Anissa K., Geyer, Susan M., Kendra, Kari L., Carson, William E.
Publicado 2019

Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer

por Johns, Andrew C, Yang, Mike, Wei, Lai, Grogan, Madison, Spakowicz, Daniel, Patel, Sandipkumar H, Li, Mingjia, Husain, Marium, Kendra, Kari L, Otterson, Gregory A, Rosko, Ashley E, Andersen, Barbara L, Carbone, David P, Owen, Dwight H, Presley, Carolyn J
Publicado 2023

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

por Haddad, Tyler C., Zhao, Songzhu, Li, Mingjia, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Lopez, Gabriella, Miah, Abdul, Wei, Lai, Tinoco, Gabriel, Riesenberg, Brian, Li, Zihai, Meara, Alexa, Bertino, Erin M., Kendra, Kari, Otterson, Gregory, Presley, Carolyn J., Owen, Dwight H.
Publicado 2021

Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma

por Sun, Steven H., Benner, Brooke, Savardekar, Himanshu, Lapurga, Gabriella, Good, Logan, Abood, David, Nagle, Erin, Duggan, Megan, Stiff, Andrew, DiVincenzo, Mallory J., Suarez-Kelly, Lorena P., Campbell, Amanda, Yu, Lianbo, Wesolowski, Robert, Howard, Harrison, Shah, Hiral, Kendra, Kari, Carson, William E.
Publicado 2021

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

por Abu-Sbeih, Hamzah, Ali, Faisal S., Naqash, Abdul Rafeh, Owen, Dwight H., Patel, Sandipkumar, Otterson, Gregory A., Kendra, Kari, Ricciuti, Biagio, Chiari, Rita, De Giglio, Andrea, Sleiman, Joseph, Funchain, Pauline, Wills, Beatriz, Zhang, Jiajia, Naidoo, Jarushka, Philpott, Jessica, Gao, Jianjun, Subudhi, Sumit K., Wang, Yinghong
Publicado 2019

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

por Spakowicz, Daniel, Hoyd, Rebecca, Muniak, Mitchell, Husain, Marium, Bassett, James S., Wang, Lei, Tinoco, Gabriel, Patel, Sandip H., Burkart, Jarred, Miah, Abdul, Li, Mingjia, Johns, Andrew, Grogan, Madison, Carbone, David P., Verschraegen, Claire F., Kendra, Kari L., Otterson, Gregory A., Li, Lang, Presley, Carolyn J., Owen, Dwight H.
Publicado 2020

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

por Markowitz, Joseph, Abrams, Zachary, Jacob, Naduparambil K, Zhang, Xiaoli, Hassani, John N, Latchana, Nicholas, Wei, Lai, Regan, Kelly E, Brooks, Taylor R, Uppati, Sarvani R, Levine, Kala M, Bekaii-Saab, Tanios, Kendra, Kari L, Lesinski, Gregory B, Howard, J Harrison, Olencki, Thomas, Payne, Philip R, Carson, William E
Publicado 2016

Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors

por Matsui, Jennifer K., Perlow, Haley K., Raj, Rohit K., Nalin, Ansel P., Lehrer, Eric J., Kotecha, Rupesh, Trifiletti, Daniel M., McClelland, Shearwood, Kendra, Kari, Williams, Nicole, Owen, Dwight H., Presley, Carolyn J., Thomas, Evan M., Beyer, Sasha J., Blakaj, Dukagjin M., Ahluwalia, Manmeet S., Raval, Raju R., Palmer, Joshua D.
Publicado 2022

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

por Silk, Ann W, Barker, Christopher A, Bhatia, Shailender, Bollin, Kathryn B, Chandra, Sunandana, Eroglu, Zeynep, Gastman, Brian R, Kendra, Kari L, Kluger, Harriet, Lipson, Evan J, Madden, Kathleen, Miller, David M, Nghiem, Paul, Pavlick, Anna C, Puzanov, Igor, Rabinowits, Guilherme, Ruiz, Emily S, Sondak, Vernon K, Tavss, Edward A, Tetzlaff, Michael T, Brownell, Isaac
Publicado 2022

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

por Tarhini, Ahmad A, Kang, Ni, Lee, Sandra J, Hodi, F Stephen, Cohen, Gary I, Hamid, Omid, Hutchins, Laura F, Sosman, Jeffrey A, Kluger, Harriet M, Eroglu, Zeynep, Koon, Henry B, Lawrence, Donald P, Kendra, Kari L, Minor, David R, Lee, Carrie B, Albertini, Mark R, Flaherty, Lawrence E, Petrella, Teresa M, Streicher, Howard, Sondak, Vernon K, Kirkwood, John M
Publicado 2021

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

por Nghiem, Paul, Bhatia, Shailender, Lipson, Evan J, Sharfman, William H, Kudchadkar, Ragini R, Brohl, Andrew S, Friedlander, Philip A, Daud, Adil, Kluger, Harriet M, Reddy, Sunil A, Boulmay, Brian C, Riker, Adam, Burgess, Melissa A, Hanks, Brent A, Olencki, Thomas, Kendra, Kari, Church, Candice, Akaike, Tomoko, Ramchurren, Nirasha, Shinohara, Michi M, Salim, Bob, Taube, Janis M, Jensen, Erin, Kalabis, Mizuho, Fling, Steven P, Homet Moreno, Blanca, Sharon, Elad, Cheever, Martin A, Topalian, Suzanne L
Publicado 2021

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

por Atkins, Michael B., Lee, Sandra J., Chmielowski, Bartosz, Tarhini, Ahmad A., Cohen, Gary I., Truong, Thach-Giao, Moon, Helen H., Davar, Diwakar, O'Rourke, Mark, Stephenson, Joseph J., Curti, Brendan D., Urba, Walter J., Brell, Joanna M., Funchain, Pauline, Kendra, Kari L., Ikeguchi, Alexandra P., Jaslowski, Anthony, Bane, Charles L., Taylor, Mark A., Bajaj, Madhuri, Conry, Robert M., Ellis, Robert J., Logan, Theodore F., Laudi, Noel, Sosman, Jeffrey A., Crockett, David G., Pecora, Andrew L., Okazaki, Ian J., Reganti, Sowjanya, Chandra, Sunandana, Guild, Samantha, Chen, Helen X., Streicher, Howard Z., Wolchok, Jedd D., Ribas, Antoni, Kirkwood, John M.
Publicado 2023

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy

por Johnson, Mariah M, Leachman, Sancy A, Aspinwall, Lisa G, Cranmer, Lee D, Curiel-Lewandrowski, Clara, Sondak, Vernon K, Stemwedel, Clara E, Swetter, Susan M, Vetto, John, Bowles, Tawnya, Dellavalle, Robert P, Geskin, Larisa J, Grossman, Douglas, Grossmann, Kenneth F, Hawkes, Jason E, Jeter, Joanne M, Kim, Caroline C, Kirkwood, John M, Mangold, Aaron R, Meyskens, Frank, Ming, Michael E, Nelson, Kelly C, Piepkorn, Michael, Pollack, Brian P, Robinson, June K, Sober, Arthur J, Trotter, Shannon, Venna, Suraj S, Agarwala, Sanjiv, Alani, Rhoda, Averbook, Bruce, Bar, Anna, Becevic, Mirna, Box, Neil, E Carson, William, Cassidy, Pamela B, Chen, Suephy C, Chu, Emily Y, Ellis, Darrel L, Ferris, Laura K, Fisher, David E, Kendra, Kari, Lawson, David H, Leming, Philip D, Margolin, Kim A, Markovic, Svetomir, Martini, Mary C, Miller, Debbie, Sahni, Debjani, Sharfman, William H, Stein, Jennifer, Stratigos, Alexander J, Tarhini, Ahmad, Taylor, Matthew H, Wisco, Oliver J, Wong, Michael K
Publicado 2017